je.st
news
Tag: arrowhead
Arrowhead Research Corp (ARWR), ValueVision Media Inc (VVTV): QVT...
2014-10-15 07:14:41| Jewelry - Topix.net
In two recent filings with the Securities and Exchange Commission, Daniel Gold 's QVT Financial and J. Carlo Cannell 's Cannell Capital revealed raising stakes in two of their holdings. QVT Financial surged its position in Arrowhead Research Corp to approximately 3.12 million shares, from some 1.82 million shares the fund disclosed in its latest 13F filing.
Tags: media
research
corp
arrowhead
Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference
2014-09-20 00:55:19| Biotech - Topix.net
Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead's chief operating officer, will present at BioCentury's 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York. Investors may access a live and archived audio webcast on the Company's website at http://ir.arrowhedresearch.com/events.cfm .
Tags: present
industry
conference
biotech
Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
2014-06-14 04:22:56| Biotech - Topix.net
Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop ARC-520, its clinical candidate against chronic hepatitis B infection.
Tags: issues
statement
property
protection
3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira
2014-03-06 19:39:45| Biotech - Topix.net
Investors have seen the biotechnology momentum continue during Wednesday's trading session, with several biotechnology stocks producing significant gains.
Tags: wednesday
winners
biotech
arrowhead
Arrowhead Announces Pricing of Underwritten Offering of Common Stock
2014-02-19 22:48:24| Biotech - Topix.net
Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced the pricing of an underwritten offering of 5,500,000 shares of its common stock, offered at a price of $18.95 per share.
Tags: stock
common
offering
pricing